Immunogenicity of infliximab in Crohn's disease

被引：0
作者：
Hanauer, SB [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 348卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2155 / 2156
页数：2
相关论文
共 5 条
  • [1] Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
    Baert, F
    Noman, M
    Vermeire, S
    Van Assche, G
    D'Haens, G
    Carbonez, A
    Rutgeerts, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) : 601 - 608
  • [2] Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
    Hanauer, SB
    Feagan, BG
    Lichtenstein, GR
    Mayer, LF
    Schreiber, S
    Colombel, JF
    Rachmilewitz, D
    Wolf, DC
    Olson, A
    Bao, WH
    Rutgeerts, P
    [J]. LANCET, 2002, 359 (9317) : 1541 - 1549
  • [3] Infliximab for the treatment of fistulas in patients with Crohn's disease
    Present, DH
    Rutgeerts, P
    Targan, S
    Hanauer, SB
    Mayer, L
    van Hogezand, RA
    Podolsky, DK
    Sands, BE
    Braakman, T
    DeWoody, KL
    Schaible, TF
    van Deventer, SJH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (18) : 1398 - 1405
  • [4] A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
    Targan, SR
    Hanauer, SB
    vanDeventer, SJH
    Mayer, L
    Present, DH
    Braakman, T
    DeWoody, KL
    Schaible, TF
    Rutgeerts, PJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (15) : 1029 - 1035
  • [5] Wagner C, 2002, GASTROENTEROLOGY, V122, pA613
1